Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

OBJECTIVE: This study was undertaken to evaluate glucocorticoid dosages and serologic findings in patients with giant cell arteritis (GCA) flares. METHODS: Patients with GCA were randomly assigned to receive double‐blind dosing with either subcutaneous tocilizumab (TCZ) 162 mg weekly plus 26‐week pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Stone, John H., Tuckwell, Katie, Dimonaco, Sophie, Klearman, Micki, Aringer, Martin, Blockmans, Daniel, Brouwer, Elisabeth, Cid, Maria C., Dasgupta, Bhaskar, Rech, Juergen, Salvarani, Carlo, Schulze‐Koops, Hendrik, Schett, Georg, Spiera, Robert, Unizony, Sebastian H., Collinson, Neil
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Vasculitis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6772126/
https://ncbi.nlm.nih.gov/pubmed/30835950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40876
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados